Application 207923
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SEEBRI | GLYCOPYRROLATE | POWDER;INHALATION | 15.6MCG/INH | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0662 | SEEBRI NEOHALER | glycopyrrolate | Novartis Pharmaceuticals Corporation | NDA | Current |
| 63402-815 | SEEBRI NEOHALER | GLYCOPYRROLATE | Sunovion Pharmacueticals Inc. | NDA | Current |
| 63402-815 | SEEBRI NEOHALER | GLYCOPYRROLATE | Sunovion Pharmacueticals Inc. | NDA | Current |
| 63402-815 | SEEBRI NEOHALER | GLYCOPYRROLATE | Sunovion Pharmacueticals Inc. | NDA | Current |
| 63402-815 | SEEBRI NEOHALER | GLYCOPYRROLATE | Sunovion Pharmacueticals Inc. | NDA | Current |